Clinical Trials

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT06435351 2026-04-01

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

16 enrolled

Phase EARLY_PHASE1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04943848 2026-03-17

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Phase 1 Recruiting

36 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT06011772 2026-03-11

EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer

2 enrolled

Phase 1 Active not recruiting

Colonic Neoplasms

NCT04015700 2026-02-09

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

9 enrolled

CNS

Glioblastoma

NCT04948619 2026-01-22

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Phase 2 Recruiting

64 enrolled

Neoplasms

NCT05264974 2026-01-21

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Phase 1 Recruiting

18 enrolled

DermatologicSarcoma

Melanoma, Sarcoma

NCT01720836 2025-10-21

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Phase 1/2 Recruiting

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06175221 2025-09-15

Autologous TLPO Vaccine Basket

Phase 2 Terminated

63 enrolled

Neoplasm Metastasis, Neoplasms

NCT06243666 2025-07-31

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Active not recruiting

2,188 enrolled

Phase 3 Active not recruiting

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06866574 2025-07-31

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

9,300 enrolled

Anus Neoplasms, Condylomata Acuminata

NCT04523688 2025-07-22

Combi G-Vax

Phase 2 Recruiting

28 enrolled

CNS

Glioblastoma

NCT00505063 2025-06-15

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

76 enrolled

Neoplasms

NCT06522919 2025-01-28

CombiCoR-Vax

Phase 2 Recruiting

36 enrolled

Colorectal Neoplasms

NCT01973322 2025-01-09

ABSIDE

34 enrolled

Dermatologic

Melanoma

NCT03092453 2024-12-24

Dendritic Cell Vaccination in Patients With Advanced Melanoma

5 enrolled 10 charts

Dermatologic

Melanoma

NCT03946358 2024-12-20

VolATIL

GastrointestinalGynecologicHead & Neck

47 enrolled

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

NCT02362464 2024-12-10

Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139

14 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT06429020 2024-05-24

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Completed

1,089 enrolled

Phase 1/2 Active not recruiting

Lymphadenopathy, Breast Neoplasms

NCT04487756 2024-04-03

VENEZO-LUNG

20 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT03629886 2024-03-15

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Phase 4 Completed

6,051 enrolled 11 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06207175 2024-01-23

A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Phase 3 Unknown

1,260 enrolled

Papillomavirus Infections

NCT05986981 2023-08-14

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Phase 2 Unknown

20 enrolled

Genitourinary

Medullary cystic kidney disease 1, Neoplasms

NCT04965350 2023-04-13

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

1,100 enrolled

Papillomavirus Infections

NCT04704908 2023-01-26

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Unknown

979 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04969445 2023-01-26

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Unknown

647 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05045755 2023-01-26

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Unknown

1,339 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05694728 2023-01-23

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

GastrointestinalGynecologic

780 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

NCT05680454 2023-01-17

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

GastrointestinalGynecologic

160 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT05672966 2023-01-06

Phase I Clinical Trial of a Candidate HPV Vaccine

Phase 1 Unknown

40 enrolled

Papillomavirus Infections

NCT05668572 2023-01-04

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Phase 3 Unknown

12,000 enrolled

Papillomavirus Infections

NCT05662020 2022-12-27

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Phase 3 Active not recruiting

2,750 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

33 enrolled 18 charts

Adenocarcinoma, Breast Neoplasms

NCT02529930 2022-07-13

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Phase 1/2 Completed

34 enrolled

High Grade Cervical Intraepithelial Neoplasia

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Phase 4 Completed

540 enrolled

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03630809 2022-04-25

Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Phase 2 Terminated

16 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT02362451 2022-03-18

Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer

Phase 2 Terminated

7 enrolled 10 charts

Genitourinary

Prostatic Neoplasms

NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

NCT01094405 2021-07-28

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

25 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Recurrence, Epstein-Barr Virus Infections

NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

237 enrolled 20 charts

Herpes Zoster

NCT02336984 2021-01-11

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Phase 1/2 Withdrawn

NCT03384316 2020-09-09

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

BreastGastrointestinalGenitourinaryThoracic

11 enrolled 18 charts

Adenoviridae Infections, Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms

NCT01031069 2020-07-21

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Phase 4 Completed

873 enrolled 34 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01896869 2020-05-19

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

83 enrolled 16 charts

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Phase NA Completed

11 enrolled 8 charts

CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

NCT00684294 2020-03-02

Auto TAG

Phase 1 Terminated

46 enrolled

Carcinoma, Neoplasms

NCT01254630 2019-09-30

V212-011

Other hematologic neoplasm

5,305 enrolled 20 charts

Herpes Zoster, Hematologic Neoplasms

NCT01460719 2019-03-11

V212-013

80 enrolled 13 charts

Herpes Zoster

NCT02566265 2019-01-30

SHIVERING 2

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01984697 2018-08-08

V503-010